SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

The SPY is seeing strong pre-market momentum as futures rally following reports of a potential de-escalation in Middle East tensions and diplomatic efforts between the U.S. and Iran. While bulls are celebrating a potential relief rally, the community remains divided, with active discussions focused on whether this is a sustainable reversal or a tactical bull trap ahead of a dense week of high-stakes corporate earnings and major economic data releases.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

Rigetti Computing is trending as investors react to new federal executive orders aimed at accelerating U.S. quantum technology leadership and secure data migration. The community is actively debating the stock's long-term potential versus concerns over high cash burn rates, recent insider selling, and the reliability of government-linked catalysts.

Venture Global, Inc. engages in the provision of United States liquefied natural gas sourced from resource rich North American natural gas basins. It operates through the following segments: Calcasieu Project, Plaquemines Project, CP2 Project, and Sales and shipping. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global is trending as investors react to a significant jump in liquefaction fees and strong production performance reported in recent filings, positioning the firm to benefit from tight global LNG supplies. The community is focused on the impact of ongoing Middle East geopolitical instability on energy export corridors, which continues to drive volatility and speculative interest in the stock.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is facing significant downward pressure as market participants debate the long-term viability of its massive AI infrastructure debt and its heavy concentration of contracts with OpenAI. While some investors are viewing the current price levels as a deep-value buying opportunity fueled by major enterprise and government partnerships, community sentiment remains highly divided between those betting on an epic turnaround and others warning of ongoing liquidity risks.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as the community prepares for a high-stakes July 29 FDA advisory committee meeting to review the regulatory application for Deramiocel in Duchenne muscular dystrophy. Investors and community members are bracing for intense volatility, closely monitoring the potential for a favorable label expansion, a short squeeze, and the impact of upcoming briefing documents on the company's valuation.

Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corporation is experiencing significant volatility driven by concerns over May commercial sales data and speculative fears regarding competitive trial readouts from AstraZeneca. While the community remains divided, many long-term investors are pointing to the upcoming J-code activation and EMA regulatory decisions as key catalysts, viewing the current price action as a buying opportunity.

ExxonMobil is an international oil and gas company, providing energy that helps underpin growing economies and improve living standards around the world. It uses innovation and technology to deliver energy to a growing world. The company explores for, produces, and sells crude oil, natural gas and petroleum products.

ExxonMobil Holdings Corp.

Exxon Mobil Corp

Exxon Mobil is currently in focus as investors weigh the stock's role as a potential hedge against ongoing geopolitical tensions in the Middle East and concerns over global energy supply constraints. The community is actively debating the impact of crude oil price fluctuations on earnings, with many users highlighting the stock's stability and share buyback programs as key reasons to remain invested despite broader market volatility.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is currently experiencing significant volatility following a disappointing earnings release, with community sentiment deeply divided between long-term investors betting on the company's future in AI and robotics, and bears focused on margin compression and high capital expenditures. Traders are actively debating whether the stock's recent sharp decline represents a generational buying opportunity or a deeper structural trend change, with heavy discussion surrounding potential institutional accumulation and the stock's critical technical support levels.

Forte Biosciences, Inc. is a biopharmaceutical company, which engages in the provision of dermatology products and services. Its lead product includes FB-401, which is a live biotherapeutic for the treatment of inflammatory skin disease, including pediatric and adult patients with atopic dermatitis. The company was founded by Paul A. Wagner on May 3, 2017 and is headquartered in Dallas, TX.

Forte Biosciences Inc

Forte Biosciences is trending following the announcement of a $53 million oversubscribed private placement to advance its FB102 drug candidate. The community is actively debating the stock's volatility and short-squeeze potential, with some traders monitoring institutional backing while others caution against the risk of dilution.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Luckin Coffee is currently drawing significant investor attention due to positive legal developments in Thailand and a high-profile presence at industry events, which are fueling community hopes for a potential rebound and eventual major exchange relisting. Despite broader market volatility in Chinese equities and ongoing debate regarding margins versus growth, long-term investors remain focused on the company's aggressive store expansion and the impact of the newly authorized share buyback program.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Rbb Fund Inc - Motley Fool Momentum Factor ETF

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Fundamentals

Info

MFMORbb Fund Inc - Motley Fool Momentum Factor ETF

Latest MFMO News